For a better browsing experience, we recommend using one of the following browsers:
On June 27th we will host at IEI senior representative from Debiopharm Innovation Fund , a sister company of Debiopharm Group which is a family-owned biopharmaceutical group of companies headquartered in Lausanne, Switzerland. Active in the life science areas of drug development, GMP manufacturing of proprietary drugs and diagnostic tools. 420 employees.
Debiopharm Innovation Fund's objective is to make strategic investments in innovative companies with technologies and business models that change the they develop drugs and treat patients.
Senior representatives from Debiopharm Innovation Fund will be having B2B meetings with several Israeli digital health companies in the field of Oncology and Infectious Disease to explore ways of cooperation and investment opportunities.
AboutIsrael Export Institute
Business Development DepartmentAgrotech Automotive and Subcontracting Cleantech and Smart ifrastructure Consumer Products Content Film TV and Music Cyber Dental Fintech Food and Beverage FoodTech Fresh Produce & Wine Homeland Security and Aerospace Medical Device and HIT Mobile, Smart Cities and Innovation Ecosystems New Media Technology Division Water Technologies
Register for get updates
Email is empty
Error while sending details